Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

Hugging Face

Hugging Face Raises $235M in Series D

81 Prospect Street, Brooklyn, NY 11201August 15, 20242 min read
Employees
200+

Hugging Face Raises $235M in Series D


Hugging Face has successfully raised $235M in a Series D at a $4.5B valuation led by Salesforce Ventures, Nvidia, Google, Amazon, AMD, Intel, IBM, Qualcomm, Sound Ventures, Lux Capital, Sequoia Capital, Coatue.


Company Overview


Hugging Face is a AI/ML company headquartered in 81 Prospect Street, Brooklyn, NY 11201, founded in 2016 with 200+ employees.


AI model repository and collaboration platform


Fundraising Details


  • Amount Raised: $235M
  • Round Type: Series D
  • Valuation: $4.5B
  • Date: 2024-08-15
  • Investors: Salesforce Ventures, Nvidia, Google, Amazon, AMD, Intel, IBM, Qualcomm, Sound Ventures, Lux Capital, Sequoia Capital, Coatue

About Hugging Face


AI model repository and collaboration platform The company is positioned in the AI/ML sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 81 Prospect Street, Brooklyn, NY 11201
  • Founded: 2016
  • Team Size: 200+
  • Industry: AI/ML

What This Means


This funding round demonstrates strong investor confidence in Hugging Face's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The AI/ML sector continues to attract significant investment as companies innovate to meet evolving market demands. Hugging Face's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $4.5B valuation marks an important milestone for Hugging Face, positioning the company among notable players in the AI/ML industry.


Looking Ahead


With this new capital, Hugging Face is well-positioned to execute on its growth strategy and continue building innovative solutions in the AI/ML space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-08-15. For more information about Hugging Face, visit their headquarters at 81 Prospect Street, Brooklyn, NY 11201.

Company Info

Headquarters
81 Prospect Street, Brooklyn, NY 11201
Founded
2016
Team Size
200+

Topics

Fundraising(2912)AI/ML(484)Series D(267)Hugging Face

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free